相关实验视频

Updated: Jan 9, 2026

Use of Rabbit Eyes in Pharmacokinetic Studies of Intraocular Drugs

Use of Rabbit Eyes in Pharmacokinetic Studies of Intraocular Drugs

Published on: July 23, 2016

德克萨米他松棕酸荷载的sHDL纳米盘:在过敏结膜炎中提高了疗效和安全性

Jiawei Li¹, Pengyue Liu¹, Yue Zhang¹

¹Department of Dermatology, Shengjing Hospital of China Medical University, Shenyang, 110004, China.

Journal of pharmaceutical analysis

|December 8, 2025

概括

一种新型的合成高密度脂蛋白 (sHDL) 纳米光盘眼滴有效治疗过敏结膜炎. 这种先进的配方改善了药物输送和安全性,为传统的皮质类固醇眼滴提供了有希望的替代品.

科学领域:

眼科医生眼科眼科
纳米技术纳米技术
药理学药理学是指药理学的学科.

背景情况:

过敏性结膜炎是一种常见的眼部疾病,需要抗炎治疗.
皮质类固醇是有效的,但受到副作用和通过常规眼滴药物输送不佳的限制.
挑战包括眼睛保留时间短和角膜透率低,导致生物利用率低于最佳.

研究的目的:

开发和评估一种新的无防腐剂合成高密度脂蛋白 (sHDL) 纳米光盘眼滴配方.
将德克萨米他松棕酸盐纳入sHDL纳米盘,以增强眼部药物输送.
在过敏结膜炎的临床前模型中评估这种纳米盘配方的疗效和安全性.

主要方法:

开发一种含有德甲棕酸盐的无防腐剂sHDL纳米光盘眼滴.
对纳米盘配方的药物稳定性和眼睛保留时间的评估.
在卵泡胺 (OVA) 诱导过敏结膜炎的小鼠模型中对纳米光盘眼滴的评估.

主要成果:

该sHDL纳米光盘眼滴配方表现出增强的药物稳定性和长时间的眼睛保留.
在小鼠模型中观察到过敏结膜炎症状的显著缓解.
纳米盘配方显示出优异的安全性和生物相容性,降低了皮质类固醇度.

结论:

没有防护剂的sHDL纳米光盘眼滴代表了对过敏结膜炎的有前途的药物输送系统.
与传统的眼药相比,这种创新方法提高了治疗效果和安全性.
这些发现支持sHDL纳米光盘在治疗眼前疾病方面的潜力.

关键词:

过敏性结膜炎是一种过敏性结膜炎.德克萨米他松棕酸盐是什么眼滴眼滴是一种眼药.纳米光盘是一个纳米盘.在Th2细胞中.sHDL sHDL 在线观看

更多相关视频

A Rabbit Model of Aqueous-Deficient Dry Eye Disease Induced by Concanavalin A Injection into the Lacrimal Glands: Application to Drug Efficacy Studies

A Rabbit Model of Aqueous-Deficient Dry Eye Disease Induced by Concanavalin A Injection into the Lacrimal Glands: Application to Drug Efficacy Studies

Published on: January 24, 2020

Slow-release Drug Delivery through Elvax 40W to the Rat Retina: Implications for the Treatment of Chronic Conditions

Slow-release Drug Delivery through Elvax 40W to the Rat Retina: Implications for the Treatment of Chronic Conditions

Published on: September 17, 2014

相关概念视频

Drug Delivery: Miscellaneous Routes

Drug Delivery: Miscellaneous Routes

Drug delivery methods like oral inhalation, nasal sprays, transdermal patches, eye drops, intravitreal injection, and rectal administration provide localized effects with reduced toxicity.
Oral inhalation and nasal sprays swiftly transfer drugs across the respiratory epithelium's mucosal layer. Inhaled glucocorticoids and bronchodilators directly target lung conditions such as asthma, while fluticasone nasal spray mitigates allergic rhinitis.
Transdermal patches transport drugs...

Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids

Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids

Inhaled corticosteroids (ICS) are anti-inflammatory drugs used primarily in treating persistent asthma and providing long-term maintenance. They target the bronchial mucosa, the lining of the airways, to control inflammation, a critical factor in asthma progression and exacerbation.
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...

Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs

Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs

Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...